Healthcare & Life Sciences
Ring Therapeutics
United Statesringtx.com/
Ring Therapeutics is a series b startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
3
Investors
About Ring Therapeutics
Ring Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Ring Therapeutics develops vector-based therapies using human commensal anelloviruses to enable targeted delivery of genetic and nucleic acid medicines through its proprietary Anellogy and Vectorology platforms.
Explore Ring Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.